Percutaneous closure of ventricular septal defects

Expert Review of Cardiovascular Therapy

Volumn 4, Issue 5, 2006, Pages 671-680

  Butera, Gianfranco ^a   Chessa, Massimo ^a   Piazza, Luciane ^a   Negura, Diana ^a   Micheletti, Angelo ^a   Carminati, Mario ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Children; Congenital heart defects; Surgery; Transcatheter; Treatment; Ventricular septal defects

Indexed keywords

NITINOL;

AORTA VALVE REGURGITATION; ARTIFICIAL EMBOLISM; ARTIFICIAL HEART PACEMAKER; COMPLETE HEART BLOCK; CONGENITAL HEART DISEASE; HEART INFARCTION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MINIMALLY INVASIVE CARDIAC SURGERY; MORBIDITY; REVIEW; SURGICAL APPROACH; SURGICAL INSTRUMENT; SURGICAL MORTALITY; TREATMENT OUTCOME;

CARDIAC SURGICAL PROCEDURES; EQUIPMENT DESIGN; HEART DISEASES; HEART SEPTAL DEFECTS, VENTRICULAR; HEART SEPTUM; HEART VENTRICLES; HUMANS; MYOCARDIAL INFARCTION; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 33750936749     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.4.5.671     Document Type: Review

References (39)

1. Rudolph AM. Ventricular septal defect. In: Congenital Diseases of the Heart: Clinical - Physiological Considerations (2nd Edition). Rudolph AM (Ed.). Futura Publishing Company, NY, USA, 197-244 (2001).
2. Lillehei CW, Cohen M, Warden HE et al. The results of direct vision closure of ventricular septal defects in eight patients by means of controlled cross circulation. Urg. Gynecol. Obstet. 101, 447 (1955).
3. Kouchoukos NT Blackstone EH, Doty DB, Hanley FL, Karp RB. Ventricular septal defect. In: Kirklin/Barrat-Boyes Cardiac Surgery (3rd Edition). Elsevier Science, USA, 850-910 (2003).
4. Roos-Hesselink JW, Meijboom FJ, Spitaels SE et al. Outcome of patients after surgical closure of ventricular septal defect at a young age: longitudinal follow-up of 22-34 years. Eur. Heart J. 25, 1057-1062 (2004).
5. Mavroudis C, Backer CL, Jacobs JP. Ventricular septal defect. In: Pediatric Cardiac Surgery (3rd Edition). Mavroudis C, Backer CL (Eds). Mosby Inc, CA, USA 298-320 (2003).
6. Nygren A, Sunnegardh J, Berggren H. Preoperative evaluation and surgery in isolated ventricular septal defects: a 21 year perspective. Heart 83, 198-204 (2005).
7. Monro JL, Alexiou C, Salmon AP, Keeton B. Follow-up and survival after primary repair of congenital heart defects in children. J. Thorac. Cardiovasc. Surg. 126, 511-520 (2003).
8. Hobbins SM, Izukawa T, Radford DJ, Williams WG, Trusler GA. Conduction disturbances after surgical correction of ventricular septal defect by the atrial approach. Br. Heart J. 41, 289-293 (1979).
9. Bol-Raap G, Weerheim J, Kappetein AP, Witsenburg M, Bogers AJ. Follow-up after surgical closure of congenital ventricular septal defect. Eur. J. Cardiothorac. Surg. 24, 511-515 (2003).
10. Visconti KJ, Bichell DP, Jonas RA, Newburger JW, Bellinger DC. Developmental outcome after surgical versus interventional closure of secundum atrial septal defect in children. Circulation 100(Suppl II), 145-150 (1999).
11. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation 78, 361-368 (1988).
12. Janorkar S, Goh T, Wilkinson J. Transcatheter closure of ventricular septal defects using the Rashkind device: initial experience. Catheter Cardiovasc. Interv. 46, 43-48 (1999).
13. Kalra GS, Verma PK, Dhall A, Singh S, Arora R. Transcatheter device closure of ventricular septal defects: immediate results and intermediate follow-up. Am. Heart J. 138, 339-344 (1999).
14. Sideris EB, Walsh KP, Haddad JL Chen C, Ren SG, Kulkarni H. Occlusion of congenital ventricular septal defects by the buttoned device. "Buttoned device" Clinical Trials International Register. Heart 77, 276-279 (1997).
15. Amin Z, Gu X, Berry JM et al. New device for closure of muscular ventricular septal defects in a canine model. Circulation 100, 320-328 (1999).
16. Thanopoulos BD, Rigby ML. Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder. Heart 91, 513-516 (2003).
17. Hijazi ZM, Hakim F, Al Fadley F, Abdelhamid J, Cao QL. Transcatheter closure of single muscular ventricular septal defects using the Amplatzer muscular VSD occluder: initial results and technical considerations. Catheter Cardiovasc. Interv. 49, 167-172 (2000).
18. Chessa M, Carminati M, Cao QL et al. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J. Invasive Cardiol. 14, 322-327 (2002).
19. Holzer R, Balzer D, Qi-Ling Cao, Lock K, Hijazi ZM; Amplatzer Muscular Ventricular Septal Defect Investigators. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder. J. Am. Coll. Cardiol. 43, 1257-1263 (2004).
20. Arora R, Trehan V, Thakur AK, Mehra V, Sengupta PP, Nigam N. Transcatheter closure of congenital muscular ventricular septal defect. J. Interv. Cardiol. 17, 109-115 (2004).
21. Carminati M, Butera. G, Chessa M, Drago M, Negura D, Piazza L. Transcatheter closure of congenital ventricular septal defects with Amplatzer occluders. Am. J. Cardiol, 96(12A), 52L-58L (2005).
22. Gu X, Han YM, Titus JL et al. Transcatheter closure of membranous ventricular septal defects with a new nitinol prosthesis in a natural swine model. Catheter Cardiovasc. Interv. 50, 502-509 (2000).
23. Hijazi ZM, Hakim F, Hawaleh AA et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc. Interv. 56, 508-515 (2002).
24. Bass JL, Kalra GS, Arora R et al. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc. Interv. 58, 238-245 (2003).
25. Thanopoulos BD, Tsaousis GS, Karanasios E, Eleftherakis NG, Paphitis C. Transcatheterer closure of a perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children. Heart 89, 918-922 (2003).
26. Hijazi ZM. Device closure of ventricular septal defects. Catheter Cardiovasc. Interv. 60, 107-114 (2003).
27. Arora R, Trehan V, Kumar A, Kalra GS, Nigam M. Transcatheter closure of congenital ventricular septal defects. Experience with various devices. J. Interven. Cardiol. 16, 83-91 (2003).
28. Fu YC, Hijazi ZM, Amin Z et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: result of the U.S. phase I trial. Circulation 110(Suppl. III), 565 (2004) (Abstract 17).
29. Pedra AC, Pedra SRF, Esteves CA et al. Percutaneous closure of perimebranous ventricular septal defects with the Amplatzer device: technical and morphological considerations. Catheter Cardiovasc. Interv. 61, 403-410 (2004).
30. Seddio F, Reddy VM, McElhinney DB, Tworetzky W, Silverman NH, Hanley FL. Multiple ventricular septal defects: how and when should they be repaired? J. Thorac. Cardiovasc. Surg. 117, 134-139 (1999).
31. Waight DJ, Bacha EA, Kahana M, Cao QL, Heitschmidt M, Hijazi ZM. Catheter therapy of swiss cheese ventricular septal defects using the Amplatzer muscular VSD occluder. Catheter Cardiovasc. Interv. 55, 355-361 (2002).
32. Butera G, Carminati M, De Luca F, Chessa M, Bini MR. Transcatheter treatment of muscular ventricular septal defect and pulmonary valvar stenosis in an infant. Catheter Cardiovasc. Interv. 55, 212-216 (2002).
33. Amin Z, Gu X, Berry JM, Titus JL Gidding SS, Rocchini AP. Perventricular closure of ventricular septal defects without cardiopulmonary bypass. Ann. Thorac. Surg. 68, 149-154 (1999).
34. Bacha EA, Cao QL, Galantowicz ME et al. Multicenter experience with perventricular device closure of muscular ventricular septal defects. Pediatr. Cardiol, 26(2), 169-175 (2005).
35. Crenshaw BS, Granger CB, Birnbaum Y et al, for the GUSTO-I Trial Investigators. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. Circulation 101, 27-32 (2000).
36. Holzer RJ, Balzer D, Amin Z et al. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: results of a US registry. Catheter Cardiovasc. Interv. 61, 196-201 (2004).
37. Labrousse L, Choukroun E, Chevalier JM et al. Surgery for post infarction ventricular septal defect (VSD): risk factors for hospital death and long term results. Eur. J. Cardiothorac. Surg. 21, 725-731 (2002).
38. Goldstein JA, Casserly IP, Balzer DT, Lee R, Lasala JM. Transcatheter closure of recurrent postmyocardial infarction ventricular septal defects utilizing the Amplatzer postinfarction VSD device: a case series. Catheter Cardiovase. Interv. 59(2), 238-243 (2003).
39. Szkutnik M, Bialkowski J, Kusa J et al. Postinfarction ventricular septal defect closure with Amplatzer occluders. Eur. J. Cardiothorac. Surg. 23(3), 323-327 (2003).